Insider Transactions in Q2 2024 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Ashu Tyagi Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
David N Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
James Healy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+9.96%
|
-
|
|
Jun 11
2024
|
Johan Wedell Wedellsborg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
Laura Hamill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+30.0%
|
-
|
|
Jun 11
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
35,000
-17.71%
|
$420,000
$12.0 P/Share
|
|
Jun 10
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
35,000
-15.04%
|
$420,000
$12.03 P/Share
|
|
Jun 10
2024
|
Gerard Ber Director |
SELL
Open market or private sale
|
Direct |
722
-30.99%
|
$8,664
$12.0 P/Share
|
|
May 31
2024
|
Bo Kruse EVP, CFO, SECRY & TREAS. |
SELL
Open market or private sale
|
Direct |
31,371
-12.95%
|
$376,452
$12.07 P/Share
|
|
May 31
2024
|
Bo Kruse EVP, CFO, SECRY & TREAS. |
BUY
Exercise of conversion of derivative security
|
Direct |
31,371
+11.47%
|
$62,742
$2.0 P/Share
|
|
May 30
2024
|
Bo Kruse EVP, CFO, SECRY & TREAS. |
SELL
Open market or private sale
|
Direct |
28,629
-11.95%
|
$343,548
$12.03 P/Share
|
|
May 30
2024
|
Bo Kruse EVP, CFO, SECRY & TREAS. |
BUY
Exercise of conversion of derivative security
|
Direct |
28,629
+10.68%
|
$57,258
$2.0 P/Share
|
|
May 23
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
7,351
-3.06%
|
$95,563
$13.0 P/Share
|
|
May 21
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
25,000
-9.43%
|
$300,000
$12.0 P/Share
|